Pancreatic Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Pancreatic Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China [Phase 4]
Phase IV study evaluating the safety and efficacy of everolimus in adults with progressive pancreatic neuroendocrine tumors in China has com…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions [NA]
This entry reports a clinical trial evaluating Joint-AI for diagnosing pancreatic solid lesions; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients [NA]
This document reports a clinical trial update for precision radiotherapy using MR-linac in pancreatic neuroendocrine tumors in MEN1 patients…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Neoadjuvant PRRT With Y-90-DOTATOC in pNET [Phase 2]
Phase 2 neoadjuvant radiopharmaceutical therapy with Y-90-DOTATOC for pancreatic neuroendocrine tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction [NA]
A completed clinical trial evaluating a minimally invasive pancreatic enucleation technique with exposure and repair/reconstruction of the m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Pancreatic Fistula After Minimally Invasive Enucleation
Clinical trial update on completion of a study evaluating pancreatic fistula after minimally invasive enucleation for benign pancreatic tumo…
-
CLINICAL_TRIALS withdrawal · 2024-10-26Clinical Trial Update: Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver [Phase 1, Phase 2]
The clinical trial NCT05610826 comparing preoperative PRRT to surgical cytoreduction for metastatic pancreatic neuroendocrine tumors to the …
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
A clinical trial is actively recruiting to evaluate pancreatic cancer screening using elastase-1 detection in combination with other examina…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in patients with advanced pancreatic neuroendocrine tumors and carcinoid tumors; results have been pos…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in advanced pancreatic neuroendocrine and carcinoid tumors; ACTIVE_NOT_RECRUITING with results posted …
-
FDA approval · 2024-09-27FDA Approved: BYNFEZIA PEN — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved BYNFEZIA PEN (octreotide acetate) under an original NDA from Sun Pharmaceutical Industries. The product is an autoinjector pen …
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients [NA]
A completed clinical trial from Yonsei University evaluated whether oral protein supplements improve nutrition and quality of life after pan…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors [Phase 2]
A Phase 2 clinical trial is evaluating nab-sirolimus in patients with well-differentiated neuroendocrine tumors of the gastrointestinal trac…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1]
DCR-MYC, an investigational therapy, was evaluated in a Phase I multicenter dose-escalation study in patients with solid tumors, multiple my…
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors
A clinical trial update reports safety and efficacy data for sunitinib in Chinese patients with progressive, advanced or metastatic well-dif…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor [NA]
A clinical trial evaluating in vitro organoid drug sensitivity-guided treatment for advanced pancreatic neuroendocrine tumor is currently re…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
This clinical trial update reports the completion of studies examining biomarkers of angiogenesis in renal cell carcinoma and neuroendocrine…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease
This clinical trial update describes a completed University Medical Center Groningen study on visualizing VEGF-producing lesions associated …
-
FDA approval · 2024-04-30FDA Approved: EVEROLIMUS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Everolimus submitted by Hikma Pharmaceuticals USA Inc. This action updates approved labeling…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: OPALINE : A Study Of Morbidity And Mortality At 2 Years
Clinical trial update for OPALINE reports morbidity and mortality outcomes at 2 years in well-differentiated, progressive pancreatic neuroen…
-
FDA approval · 2023-08-21FDA Approved: SUNITINIB MALATE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for SUNITINIB MALATE (sunitinib malate) filed by NorthStar RxLLC.
-
FDA approval · 2023-08-21FDA Approved: SUNITINIB MALATE — Original Application (Novugen Pharma (USA) LLC.)
FDA approves a generic version of sunitinib malate from Novugen Pharma (USA) LLC under an Original Application (ANDA 218012).
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 2]
Phase 2 clinical trial update for cabozantinib in advanced pancreatic neuroendocrine tumors and carcinoid tumors has completed with results …
-
FDA approval · 2023-06-30FDA Approved: OCTREOTIDE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for octreotide acetate filed by Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET [Phase 2]
Phase 2 trial update on neoadjuvant PRRT with 177Lu-DOTATATE followed by surgery for resectable pancreatic neuroendocrine tumors (PanNET).